Access to this On Demand webinar is by request only. Click here to request access.

In this webinar, a joint team of advisors from Verpora and Manatt Health, who span the world of negotiation strategy, legal and regulatory counsel, government health technology assessment, and the science of human performance factors, share their: 

• Unique approach to helping brands navigate IPAY 2026 negotiations 

• Vital learnings from the process 

• Critical recommendations for future negotiations  

• Essential do’s and don’ts  

A must-watch webinar for any manufacturer preparing for IPAY 2027 and beyond!

Viewers of this webinar will…

• Gain the inside track on how to structure the brand for success 

• Save time and organizational resources during your preparations 

• Optimize future negotiations 

• Ask questions to those who lived through the IPAY 2026 process 

Preparing for the next wave of the Medicare Drug Price Negotiations? Use Verpora’s knowledge to build a stronger negotiation team to tackle IPAY 2027 head-on

If you would like to extend the conversation with the Verpora and/or Manatt Health team, please email your enquiry to info@verpora.com

Request Access

To request your pass code to view this webinar, please complete the form below. Please note that we only grant access to requests from professional work email domains.

Speakers

Nick Merryfield
CEO,
Verpora

Omar Ali
Head of Payers, Verpora

Chris Webber
Head of Negotiation, Verpora

Erin Estey Hertzog
Partner,
Manatt Health

Ross Margulies
Partner,
Manatt Health

Background 

In 2023, ten brand’s manufacturers were the first to be compelled to negotiate Maximum Fair Prices (MFP) for Medicare Part D drugs with the Centers for Medicare & Medicaid Services. Results of this process reveal a significant variance across each of these new MFPs and the existing, estimated, average net prices for each of the products: 

Reference 1 & 2. Source: https://www.manatt.com/insights/newsletters/health-highlights/the-inflation-reduction-act-infographic-overview-o 

While there may be many reasons for the differences, the joint team of advisors from Verpora and Manatt Health outline their key strategies to minimize the delta based on their experience working together with manufacturers during this process.  

Core themes covered:  

• Importance of early preparation 

• Building, training and empowering the right cross-functional team 

• Potential submission mistakes and omissions 

• Payer psychology and the science of human factors in government negotiations 

• Setting and executing the negotiation strategy